10,265 followers
New Research: Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis: Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA receptor… https://t.c